Replies to post #171802 on Biotech Values

[oc631]

ENTA might be a reasonable vote in the iHub survey under consideration.

Please put it in for me. As for your tax treatment, I suspect you wouldn't complain loudly if a deal was done at a large premium early next year.

[DewDiligence]

New iHub survey: Which drug/biotech company will be the first to be acquired in 2014?

We need about 8-10 names to have a worthwhile survey, so the floor is open for nominations. Thanks in advance to anyone who contributes one or more names.

(‘oc631’ already nominated ENTA.)